You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 114 No. 11, November 1996 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  CLINICAL SCIENCES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (153)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Chemoreduction in the Initial Management of Intraocular Retinoblastoma

Carol L. Shields, MD; Patrick De Potter, MD; Bruce P. Himelstein, MD; Jerry A. Shields, MD; Anna T. Meadows, MD; John M. Maris, MD

Arch Ophthalmol. 1996;114(11):1330-1338.


Abstract



Background
Chemoreduction is a method of reducing tumor volume to allow for more focused, less damaging therapeutic measures.

Objective
To determine whether chemoreduction could be used to decrease the size of retinoblastoma so that enucleation or external beam radiotherapy could be avoided and more conservative modalities employed.

Methods
A prospective pilot study was performed to assess the effectiveness of a 2-month chemoreduction regimen of vincristine sulfate, etoposide, and carboplatin in patients with retinoblastoma. The study included 20 patients with 54 tumors in 31 eyes.

Results
At the initial examination, the mean tumor base was 12 mm and the thickness, 7 mm. Vitreous seeds were present in 14 eyes (45%). A secondary retinal detachment was present in 24 eyes (77%) and, when present, involved a mean of 71% of the retina. In 11 eyes (36%) the retina was totally detached with serous subretinal fluid. After 2 months of chemoreduction, all 54 tumors showed regression in size, and 48 (89%) showed evidence of calcification. The mean tumor base was 8 mm and the thickness, 4 mm. Overall, there was a mean 35% decrease in base and 49% decrease in thickness of the tumor at the end of the treatment period. A complete response was found in 25 tumors (46%) and a partial response in 29 (54%). The subretinal fluid had resolved completely in 50% of the cases (12/24 eyes), and, in the 11 eyes with total retinal detachment, the subretinal fluid had completely resolved, leaving flat retina, in 6 eyes (54%). The vitreous seeds demonstrated some degree of regression in all cases, and in 5 eyes there was 90% to 100% calcification of the seeds. Short-term systemic toxic effects were mild (transient bone marrow suppression). Enucleation was avoided in all cases; external beam radiotherapy was necessary in 9 eyes because of diffuse vitreous seeds. The remaining 22 eyes were treated with local methods after chemoreduction.

Conclusion
Tumor shrinkage with chemoreduction may allow treatment with less invasive measures, such as cryotherapy, laser photocoagulation, thermotherapy, or plaque radiotherapy, thereby avoiding enucleation and external beam radiotherapy.



Author Affiliations



From the Ocular Oncology Service, Wills Eye Hospital Service, Thomas Jefferson University, Philadelphia, Pa (Drs C. Shields, De Potter, and J. Shields); and the Division of Oncology, The Children's Hospital of Philadelphia (Drs Himelstein, Meadows, and Maris).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evolution in Regression Patterns Following Chemoreduction for Retinoblastoma
Palamar et al.
Arch Ophthalmol 2011;129:727-730.
ABSTRACT | FULL TEXT  

Treating Retinoblastoma in Tissue Culture and in a Rat Model with a Novel Isoquinoline Derivative
Nassr et al.
IOVS 2010;51:3813-3819.
ABSTRACT | FULL TEXT  

Emerging options in the management of advanced intraocular retinoblastoma
Honavar
Br J Ophthalmol 2009;93:848-849.
FULL TEXT  

Retinoblastoma Regression Patterns Following Chemoreduction and Adjuvant Therapy in 557 Tumors
Shields et al.
Arch Ophthalmol 2009;127:282-290.
ABSTRACT | FULL TEXT  

Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival
Naseripour et al.
Br J Ophthalmol 2009;93:28-32.
ABSTRACT | FULL TEXT  

Clinical manifestations and treatment of retinoblastoma in Korea
Chung et al.
Br J Ophthalmol 2008;92:1180-1184.
ABSTRACT | FULL TEXT  

The Adverse Events of Chemotherapy for Retinoblastoma: What Are They? Do We Know?
Rizzuti et al.
Arch Ophthalmol 2008;126:862-865.
FULL TEXT  

Retinoblastoma: Review of Current Management
Chintagumpala et al.
The Oncologist 2007;12:1237-1246.
ABSTRACT | FULL TEXT  

Socioeconomic Impact of Modern Multidisciplinary Management of Retinoblastoma
Wilson et al.
Pediatrics 2006;118:e331-e336.
ABSTRACT | FULL TEXT  

Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleation.
Wilson et al.
IOVS 2006;47:1269-1273.
ABSTRACT | FULL TEXT  

Systemic carboplatin for retinoblastoma: change in tumour size over time
Abramson et al.
Br J Ophthalmol 2005;89:1616-1619.
ABSTRACT | FULL TEXT  

Response of Retinoblastoma With Vitreous Tumor Seeding to Adenovirus-Mediated Delivery of Thymidine Kinase Followed by Ganciclovir
Chevez-Barrios et al.
JCO 2005;23:7927-7935.
ABSTRACT | FULL TEXT  

Long-term Visual Outcome Following Chemoreduction for Retinoblastoma
Demirci et al.
Arch Ophthalmol 2005;123:1525-1530.
ABSTRACT | FULL TEXT  

Intraocular Surgery After Treatment of Germline Retinoblastoma
Moshfeghi et al.
Arch Ophthalmol 2005;123:1008-1012.
FULL TEXT  

Macular Retinoblastoma Managed With Chemoreduction: Analysis of Tumor Control With or Without Adjuvant Thermotherapy in 68 Tumors
Shields et al.
Arch Ophthalmol 2005;123:765-773.
ABSTRACT | FULL TEXT  

Cyclosporin A Inhibits Calcineurin/Nuclear Factor of Activated T-Cells Signaling and Induces Apoptosis in Retinoblastoma Cells
Eckstein et al.
IOVS 2005;46:782-790.
ABSTRACT | FULL TEXT  

Chemoreduction With Topical Mitomycin C Prior to Resection of Extensive Squamous Cell Carcinoma of the Conjunctiva
Shields et al.
Arch Ophthalmol 2005;123:109-113.
FULL TEXT  

Multidrug resistant proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma
Krishnakumar et al.
Br J Ophthalmol 2004;88:1521-1526.
ABSTRACT | FULL TEXT  

Pharmacokinetics of Systemic Versus Focal Carboplatin Chemotherapy in the Rabbit Eye: Possible Implication in the Treatment of Retinoblastoma
Hayden et al.
IOVS 2004;45:3644-3649.
ABSTRACT | FULL TEXT  

Outcome Following Initial External Beam Radiotherapy in Patients With Reese-Ellsworth Group Vb Retinoblastoma
Abramson et al.
Arch Ophthalmol 2004;122:1316-1323.
ABSTRACT | FULL TEXT  

Visual Fields in Retinoblastoma Survivors
Abramson et al.
Arch Ophthalmol 2004;122:1324-1330.
ABSTRACT | FULL TEXT  

Practical Approach to Management of Retinoblastoma
Shields et al.
Arch Ophthalmol 2004;122:729-735.
ABSTRACT | FULL TEXT  

External Beam Radiation "Salvage" Therapy in Transgenic Murine Retinoblastoma
Sobrin et al.
Arch Ophthalmol 2004;122:251-257.
ABSTRACT | FULL TEXT  

Development of New Retinoblastomas After 6 Cycles of Chemoreduction for Retinoblastoma in 162 Eyes of 106 Consecutive Patients
Shields et al.
Arch Ophthalmol 2003;121:1571-1576.
ABSTRACT | FULL TEXT  

Ocular Motility Changes After Subtenon Carboplatin Chemotherapy for Retinoblastoma
Mulvihill et al.
Arch Ophthalmol 2003;121:1120-1124.
ABSTRACT | FULL TEXT  

Histopathologic Findings in Eyes With Retinoblastoma Treated Only With Chemoreduction
Demirci et al.
Arch Ophthalmol 2003;121:1125-1131.
ABSTRACT | FULL TEXT  

High resolution magnetic resonance imaging of retinoblastoma
Schueler et al.
Br J Ophthalmol 2003;87:330-335.
ABSTRACT | FULL TEXT  

Chemoreduction for Unilateral Retinoblastoma
Shields et al.
Arch Ophthalmol 2002;120:1653-1658.
ABSTRACT | FULL TEXT  

Postenucleation Adjuvant Therapy in High-Risk Retinoblastoma
Honavar et al.
Arch Ophthalmol 2002;120:923-931.
ABSTRACT | FULL TEXT  

Factors Predictive of Recurrence of Retinal Tumors, Vitreous Seeds, and Subretinal Seeds Following Chemoreduction for Retinoblastoma
Shields et al.
Arch Ophthalmol 2002;120:460-464.
ABSTRACT | FULL TEXT  

Hyperfractionated External Beam Radiation Therapy in the Treatment of Murine Transgenic Retinoblastoma
Hayden et al.
Arch Ophthalmol 2002;120:353-359.
ABSTRACT | FULL TEXT  

Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age
Gombos et al.
Br J Ophthalmol 2002;86:80-83.
ABSTRACT | FULL TEXT  

Intraocular Surgery After Treatment of Retinoblastoma
Honavar et al.
Arch Ophthalmol 2001;119:1613-1621.
ABSTRACT | FULL TEXT  

Chemoreduction for Retinoblastoma May Prevent Intracranial Neuroblastic Malignancy (Trilateral Retinoblastoma)
Shields et al.
Arch Ophthalmol 2001;119:1269-1272.
ABSTRACT | FULL TEXT  

The Treatment of Retinoblastoma: A Case Study
Tomlinson
Journal of Pediatric Oncology Nursing 2001;18:50-54.
ABSTRACT  

Subconjunctival Carboplatin in Retinoblastoma: Impact of Tumor Burden and Dose Schedule
Hayden et al.
Arch Ophthalmol 2000;118:1549-1554.
ABSTRACT | FULL TEXT  

First-Line Chemotherapy With Local Treatment Can Prevent External-Beam Irradiation and Enucleation in Low-Stage Intraocular Retinoblastoma
Beck et al.
JCO 2000;18:2881-2887.
ABSTRACT | FULL TEXT  

Chemoreduction and Local Ophthalmic Therapy for Intraocular Retinoblastoma
Friedman et al.
JCO 2000;18:12-12.
ABSTRACT | FULL TEXT  

Chemoreduction for Retinoblastoma May Prevent Trilateral Retinoblastoma
Shields et al.
JCO 2000;18:236-236.
FULL TEXT  

Obtaining Maximal Optic Nerve Length During Enucleation Procedures
Coats et al.
Arch Ophthalmol 2000;118:70-73.
ABSTRACT | FULL TEXT  

Importance of early diagnosis of retinoblastoma
SHIELDS
Br J Ophthalmol 1999;83:1315-1316.
FULL TEXT  

Thermotherapy for Retinoblastoma
Shields et al.
Arch Ophthalmol 1999;117:885-893.
ABSTRACT | FULL TEXT  

The Outcome of Chemoreduction Treatment in Patients With Reese-Ellsworth Group V Retinoblastoma
Gunduz et al.
Arch Ophthalmol 1998;116:1613-1617.
ABSTRACT | FULL TEXT  

Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results
Levy et al.
Br J Ophthalmol 1998;82:1154-1158.
ABSTRACT | FULL TEXT  

Intraocular Concentrations of Chemotherapeutic Agents After Systemic or Local Administration
Mendelsohn et al.
Arch Ophthalmol 1998;116:1209-1212.
ABSTRACT | FULL TEXT  

Clinicopathologic Features of Retinoblastoma After Primary Chemoreduction
Bechrakis et al.
Arch Ophthalmol 1998;116:887-893.
ABSTRACT | FULL TEXT  

Subconjunctival Carboplatin Therapy and Cryotherapy in the Treatment of Transgenic Murine Retinoblastoma
Murray et al.
Arch Ophthalmol 1997;115:1286-1290.
ABSTRACT  

Ophthalmology
Levin
JAMA 1997;277:1881-1883.
 

Penetration of Chemotherapy Into Vitreous Is Increased by Cryotherapy and Cyclosporine in Rabbits
Wilson et al.
Arch Ophthalmol 1996;114:1390-1395.
ABSTRACT  

A New Era for the Treatment of Retinoblastoma
Ferris and Chew
Arch Ophthalmol 1996;114:1412-1412.
ABSTRACT  

Bilateral Macular Retinoblastoma Managed by Chemoreduction and Chemothermotherapy
Shields et al.
Arch Ophthalmol 1996;114:1426-1427.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.